Transplanting Individuals with Alcohol-related Hepatitis: Multidisciplinary Evaluation and Management
Robert Brown, MD, MPH • Gladys and Roland Harriman Professor of Medicine, Weill Cornell Medical College, New York, NY
Akhil Shenoy, MD, MPH • Assistant Professor of Psychiatry, Columbia University Department of Psychiatry, New York, NY
Michael Curry, MD • Associate Professor of Medicine, Harvard Medical School, Boston, MA
Objectives for the "Transplanting Individuals with Alcohol-related Hepatitis: Multidisciplinary Evaluation and Management" webinar include enabling the attendee to:
- Appreciate the changing landscape of liver transplantation for patients with alcohol use disorder (AUD) and alcohol related liver disease (ALD).
- Describe the diagnosis of AUD and distinguish the various treatments of AUD and how they work.
- Recognize the key management aspects of and role of transplant evaluation in alcohol-related hepatitis from a medical and psychosocial perspective.
AST would like to thank the Psychosocial and Ethics Community of Practice (PSECOP) for recommending "transplanting individuals with alcoholic hepatitis" as a topic for the 2019-2020 T3 series. Learn more about AST's COPs at www.myast.org/cops.
Educational Content Disclaimer: The content, information, opinions, and viewpoints contained in educational materials housed on and linked from the AST web site are those of the authors or contributors of such materials. While the AST and its committees take great care to screen the credentials of the contributors and make every attempt to review the contents, AST MAKES NO WARRANTY, EXPRESSED OR IMPLIED, as to the completeness or accuracy of the content contained in the educational materials or on this website. The reader of these materials uses these materials at his or her own risk, and AST shall not be responsible for any errors, omissions, or inaccuracies in these materials, whether arising through negligence, oversight, or otherwise. Reliance on any information appearing on this site is strictly at your own risk. Read the full disclaimer.